BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 76.51M | 70.80M | 65.30M | 62.58M | 55.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.51M | 70.80M | 65.30M | 62.58M | 55.58M |
| Cost of Revenue | 19.72M | 17.24M | 15.28M | 11.91M | 9.21M |
| Gross Profit | 56.79M | 53.56M | 50.01M | 50.67M | 46.37M |
| SG&A Expenses | 48.92M | 46.59M | 45.27M | 45.14M | 45.94M |
| Depreciation & Amortization | 2.32M | 2.30M | 2.28M | 1.67M | 2.07M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.02M | 73.50M | 70.07M | 66.17M | 66.36M |
| Operating Income | -2.51M | -2.70M | -4.77M | -3.59M | -10.78M |
| Income Before Tax | -16.33M | -6.18M | -8.93M | 891.00K | -13.07M |
| Income Tax Expenses | -19.00K | -144.00K | -141.00K | -243.00K | -100.00K |
| Earnings from Continuing Operations | -16.32 | -6.04 | -8.79 | 1.13 | -12.97 |
| Earnings from Discontinued Operations | 10.79M | -4.37M | -11.40M | -48.73M | -62.06M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.53M | -10.41M | -20.18M | -47.60M | -75.03M |
| EBIT | -2.51M | -2.70M | -4.77M | -3.59M | -10.78M |
| EBITDA | 3.94M | 4.74M | 3.56M | 5.75M | -576.00K |
| EPS Basic | -0.11 | -0.23 | -0.45 | -1.05 | -1.68 |
| Normalized Basic EPS | -0.01 | -0.03 | -0.07 | -0.05 | -0.16 |
| EPS Diluted | -0.12 | -0.24 | -0.46 | -1.05 | -1.68 |
| Normalized Diluted EPS | -0.01 | -0.03 | -0.07 | -0.05 | -0.16 |
| Average Basic Shares Outstanding | 187.76M | 185.96M | 184.26M | 182.43M | 179.83M |
| Average Diluted Shares Outstanding | 189.14M | 187.35M | 185.64M | 182.43M | 179.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |